Category Archives: potent compound safety

Risk-MaPP, ADEs and PDEs: Importance to multi-product pharmaceutical manufacturing facilities

In Episode 22 of the Biopharma EHS podcast, Dean M. Calhoun, CIH, President of Affygility Solutions, interviews Ms. Stephanie Wilkins, President of PharmaConsult US, regarding the topic of Risk-MaPP, ADEs and PDEs: Their importance to multi-product pharmaceutical manufacturing facilities. The … Continue reading

Posted in Acceptable Daily Exposure, potent compound safety | Leave a comment

Potent Compound Safety Video Now Available in Streaming Format

Potent Compound Safety Training Made Easy! Affygility Solutions is pleased to announce that its Introduction to Potent Compound Safety training video is now available in streaming format for only $59 on a pay-per-view basis. This price includes two views. In … Continue reading

Posted in potent compound safety | Leave a comment

Dimethyl fumarate OEL Fastrac monograph now available

Dimethyl Fumarate (DMF) requires advance handling precautions in an occupational exposure setting. IMPORTANT: Dimethyl fumarate (DMF) is a severe dermal sensitizer and advance handling precautions need to be taken before handling this compound in an occupational exposure setting. In addition, … Continue reading

Posted in OEL Fastrac, potent compound safety | Leave a comment

Dean Calhoun to present at the Pharmatek booth during AAPS 2014

Affygility Solutions’ President and CEO, Dean Calhoun, CIH will be presenting “The Future of Pharmaceutical Manufacturing – the Next 100 Years,” during the American Association of Pharmaceutical Scientists (AAPS) annual convention. Mr. Calhoun’s presentation will be on November 4th, 2014 … Continue reading

Posted in conferences, pharmaceutical contract manufacturers, potent compound safety | 1 Comment